AAP
VMD icon

Arax Advisory Partners’s Viemed Healthcare VMD Stock Holding History

Arax Advisory Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Buy
1,814
+1,784
+5,947% +$17.7K ﹤0.01% 3937
2026
Q1 		$276 Buy
+30
New +$250 ﹤0.01% 3503
2025
Q4 		– Sell
-861
Closed -$5.85K – 4553
2025
Q3 		$5.85K Buy
+861
New +$5.83K ﹤0.01% 2817
2025
Q1 		– Sell
-47
Closed -$377 – 3060
2024
Q4 		$377 Sell
47
-26
-36% -$226 ﹤0.01% 2348
2024
Q3 		$536 Hold
73
– – ﹤0.01% 2392
2024
Q2 		$479 Buy
+73
New +$550 ﹤0.01% 2338

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Arax Advisory Partners's VMD Position: Q2 2026 in Review

Arax Advisory Partners increased its Viemed Healthcare (VMD) stake by 5,947% in Q2 2026, buying an estimated $17.7K and bringing the position to 1,814 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3937.

Arax Advisory Partners first reported a position in VMD in Q2 2024 and has held it in 6 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Arax Advisory Partners held 1,814 shares of Viemed Healthcare worth $20.7K as of Q2 2026.
  • Arax Advisory Partners bought 1,784 Viemed Healthcare shares in Q2 2026, an estimated $17.7K.
  • Viemed Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3937 holding.
  • Arax Advisory Partners first reported a position in Viemed Healthcare in Q2 2024 and has held it in 6 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.